Načítá se...
Mechanisms and Drug Development in Atrial Fibrillation
Atrial fibrillation is a highly prevalent cardiac arrhythmia and the most important cause of embolic stroke. Although genetic studies have identified an increasing assembly of AF-related genes, the impact of these genetic discoveries is yet to be realized. In addition, despite more than a century of...
Uloženo v:
| Vydáno v: | Pharmacol Rev |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
The American Society for Pharmacology and Experimental Therapeutics
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6010660/ https://ncbi.nlm.nih.gov/pubmed/29921647 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1124/pr.117.014183 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|